By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antidotes > Deferoxamine > Deferoxamine Dosage
Antidotes
https://themeditary.com/dosage-information/deferoxamine-dosage-9105.html

Deferoxamine Dosage

Drug Detail:Deferoxamine (Deferoxamine [ de-fer-ox-a-meen ])

Drug Class: Antidotes Chelating agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Iron Poisoning - Acute

Initial dose: 1000 mg, IM or IV (maximum IV rate: 15 mg/kg/hour)
Maintenance dose: 500 mg, IM or IV, every 4 hours, for 2 doses; additional 500 mg doses every 4 to 12 hours may be given based on clinical response
Maximum dose: 6000 mg per 24 hour period

Comments:

  • IM administration is preferred for all patients not in shock.
  • Slow IV administration should only be used for cardiovascular collapse.
  • As soon as the clinical condition allows, discontinue IV and switch to IM administration.
  • This drug is an adjunct to, not a substitute for, standard treatment for acute iron intoxication (e.g. inducing emesis, gastric lavage)

Use: Acute iron poisoning

Usual Adult Dose for Iron Poisoning - Chronic

1000 to 2000 mg, subcutaneously over 8 to 24 hours, daily
or
40 to 50 mg/kg/day, IV over 8 to 12 hours (maximum IV rate: 15 mg/kg/hour), 5 to 7 days per week
Maximum IV dose: 60 mg/kg/day
or
500 to 1000 mg, IM,
Maximum IM dose: 1000 mg/day

Comments:

  • Subcutaneous administration is recommended.
  • Intravenous administration can be used in patients with intravenous access.

Use: Chronic iron overload

Usual Pediatric Dose for Iron Poisoning - Acute

3 years and older:
Initial dose: 1000 mg, IM or IV (maximum IV rate: 15 mg/kg/hour)
Maintenance dose: 500 mg, IM or IV, every 4 hours, for 2 doses; additional 500 mg doses every 4 to 12 hours may be given based on clinical response
Maximum dose: 6000 mg per 24 hour period

Comments:

  • IM administration is preferred for all patients not in shock.
  • Slow IV administration should only be used for cardiovascular collapse.
  • As soon as the clinical condition allows, discontinue IV and switch to IM administration.
  • This drug is an adjunct to, not a substitute for, standard treatment for acute iron intoxication (e.g. inducing emesis, gastric lavage)

Use: Acute iron poisoning

Usual Pediatric Dose for Iron Poisoning - Chronic

3 years and older:
1000 to 2000 mg, subcutaneously over 8 to 24 hours, daily
or
20 to 40 mg/kg/day, IV over 8 to 12 hours (maximum IV rate: 15 mg/kg/hour), 5 to 7 days per week
Maximum IV dose: 40 mg/kg/day (until growth has ceased)
or
500 to 1000 mg, IM,
Maximum IM dose: 1000 mg/day

Comments:

  • Monitor for body weight and growth every 3 months.
  • Subcutaneous administration is recommended.
  • Intravenous administration can be used in patients with intravenous access.

Use: Chronic iron overload

Renal Dose Adjustments

Contraindicated in severe renal impairment

Liver Dose Adjustments

Data not available

Dose Adjustments

Chronic Iron Overload:

  • Poorly compliant patients can receive their IV dose prior to or following same day blood transfusion.
  • Do not administer concomitantly with blood transfusion: errors in interpreting side effects can occur.

Precautions

Safety and efficacy have not been established in patients younger than 3 years.

Consult WARNINGS section for additional precautions.

Dialysis

Deferoxamine is dialyzable; however, no dose adjustment guidelines have been reported.

Other Comments

Administration advice:

  • Administer immediately (starting within 3 hours) after reconstitution.
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by